I had to do a good amount of digging to find this info...
I've been trying to find a good way to keep Jake's albumin levels up, and wanted to know if egg powder could work as well as regular egg whites, because... raw eggs just gross me out. Ever since I was a kid and saw that one scene from Rocky where he makes the raw egg shake.... eugh, I get the willies just thinking about it.
I'd seen raw egg white powder at Trader Joe's, and I've heard that raw egg white is 100% albumin! So I wanted to know if raw egg white could do the same thing as regular egg white.
I still don't know the answer for that (meaning, is powdered egg white just as effective as raw egg white) but it DOES seem to be beneficial for raising albumin levels.
Please note, if you have cirrhosis, please DO NOT try to consume RAW egg whites, just because you are at a very high risk for a bacterial infection, and God forbid you wind up with Salmonella poisoning. You can die from eating raw oysters when you have stage 4 cirrhosis, because you can wind up with sepsis, and I just looked up salmonella and sure enough this can cause sepsis also, so.... personally I wouldn't chance it!!!
This is the part I had to dig for (it's in the study below, I'm just copying and pasting this part):
In another study, egg albumin-powder supplementation successfully increased serum albumin in peritoneal dialysis patients but unlike liquid egg whites, the egg albumin powder did not decrease serum phosphorus levels that may be related to phosphorus-based additives (Gonzalez-Espinoza et al. 2005).
The full study is below, but before you read that, I want to show you, I just discovered they actually make ALBUMIN SUPPLEMENTS.... and it has good reviews. You can see it by CLICKING HERE. I'm just seeing this on Amazon for the first time today (11-17-17). I just saw it while looking for powdered egg whites, and today is the first time I actually typed in "albumin" instead of "powdered egg whites." I wish I had tried that a long time ago!
It's helpful to know why you need albumin. Michael Linares does a good job of explaining why you need it, in the video below. Though I disagree that a liver transplant is the best thing you could do for someone who needs help, I do like his videos and they're really informative. And I LOVE it that he teaches Med students that it's important to educate them about what's going on, and encourage them to make healthier choices.
Basically, albumin acts like a magnet that attracts water and fluid into the veins. But when you don't have that magnetic pull, the fluid leaks all over the body. Albumin also transports drugs, and binds heavily to calcium. So, if you lack albumin, your calcium levels will go down, and your ability to transport drugs will also go down. A normal level albumin level is 3.5 to 5.0 (same as your potassium).
What kills me is how doctors give albumin while you're in the hospital, but ONLY while you're in the hospital. Shouldn't they be either giving patients some of this stuff to take home with them, so they don't wind up BACK in the hospital, or giving you some kind of supplement for it, or a recommendation of some sort, like for powdered egg whites (which is PURE albumin)????
But I guess if people stopped needing to do those paracentesis procedures, they'd lose a ton of revenue!! (No offense to Michael Linares, I don't wanna say anything bad about this guy cause he is so damn helpful... he really tries to let people know what's going on, which most doctors don't do : /).
DIETARY EGG WHITES FOR PHOSPHORUS CONTROL IN MAINTENANCE HAEMODIALYSIS PATIENTS: A PILOT STUDY
SERUM PHOSPHORUS AND ALBUMIN, AND PHOSPHORUS BINDER
- Achinger SG, Ayus JC. Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor? Journal of American Society of Nephrology. 2006;17:S255–S261. [PubMed]
- Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. American Journal of Kidney Diseases. 1998;31:607–617. [PubMed]
- Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. Journal of American Society of Nephrology. 2004;15:2208–2218.[PubMed]
- Carrero JJ, Qureshi AR, Axelsson J, et al. Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. The American Journal of Clinical Nutrition. 2007;85:695–701.[PubMed]
- Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney International. 2008;73:391–398.[PubMed]
- Gonzalez-Espinoza L, Gutierrez-Chavez J, del Campo FM, et al. Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis. Peritoneal Dialysis International. 2005;25:173–180.[PubMed]
- Gupta A, Winer K, Econs MJ, et al. FGF-23 is elevated by chronic hyperphosphatemia. The Journal of Clinical Endocrinology and Metabolism. 2004;89:4489–4492. [PubMed]
- Gutierrez O, Isakova T, Rhee E, et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. Journal of American Society of Nephrology. 2005;16:2205–2215. [PubMed]
- Hernandez JD, Wesseling K, Salusky IB. Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy. Seminars in Dialysis. 2005;18:290–295. [PubMed]
- Hruska KA, Teitelbaum SL. Renal osteodystrophy. The New England Journal of Medicine. 1995;333:166–174. [PubMed]
- Hruska KA, Saab G, Mathew S, et al. Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Seminars in Dialysis. 2007;20:309–315. [PubMed]
- Ikizler TA. Protein and energy: recommended intake and nutrient supplementation in chronic dialysis patients. Seminars in Dialysis. 2004;17:471–478. [PubMed]
- Ikizler TA. Effects of hemodialysis on protein metabolism. Journal of Renal Nutrition. 2005;15:39–43.[PubMed]
- Kalantar-Zadeh K, Kopple JD, Block G, et al. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. Journal of American Society of Nephrology. 2001;12:2797–2806. [PubMed]
- Kalantar-Zadeh K, Ikizler TA, Block G, et al. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. American Journal of Kidney Diseases. 2003a;42:864–881.[PubMed]
- Kalantar-Zadeh K, Block G, Humphreys MH, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney International. 2003b;63:793–808. [PubMed]
- Kalantar-Zadeh K, Block G, McAllister CJ, et al. Appetite and inflammation, nutrition, anemia and clinical outcome in hemodialysis patients. The American Journal of Clinical Nutrition. 2004;80:299–307. [PubMed]
- Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrology, Dialysis, Transplantation. 2005a;20:1880–1888. [PubMed]
- Kalantar-Zadeh K, Braglia A, Chow J, et al. An anti-inflammatory and antioxidant nutritional supplement for hypoalbuminemic hemodialysis patients: a pilot/feasibility study. Journal of Renal Nutrition 1. 2005b;5:318–331. [PubMed]
- Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney International. 2006b;70:771–780.[PubMed]
- Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al. Risk factor paradox in wasting diseases. Current Opinion in Clinical Nutrition and Metabolic Care. 2007a;10:433–442. [PubMed]
- Kalantar-Zadeh K, Kovesdy CP, Derose SF, et al. Racial and survival paradoxes in chronic kidney disease. Nature Clinical Practice. Nephrology. 2007b;3:493–506. [PubMed]
- Kalantar-Zadeh K, Regidor DL, Kovesdy CP, et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation. 2009;119:671–679.[PMC free article] [PubMed]
- Kalantar-Zadeh K, Gutekunst L, Mehrotra R, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clinical Journal of the American Society of Nephrology. 2010;5:519–530. [PubMed]
- Kalantar-Zadeh K, Unruh M. Health related quality of life in patients with chronic kidney disease. International Urology and Nephrology. 2005;37:367–378. [PubMed]
- Kopple JD. The National Kidney Foundation K/DOQI clinical practice guidelines for dietary protein intake for chronic dialysis patients. American Journal of Kidney Diseases. 2001;38:S68–S73.[PubMed]
- Kovesdy CP, Kalantar-Zadeh K. Bone and mineral disorders in pre-dialysis CKD. International Urology and Nephrology. 2008;40:427–440. [PubMed]
- Kovesdy CP, Kalantar-Zadeh K. Why is protein-energy wasting associated with mortality in chronic kidney disease? Seminars in Nephrology. 2009;29:3–14. [PubMed]
- Kovesdy CP, George SM, Anderson JE, et al. Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. The American Journal of Clinical Nutrition. 2009;90:407–414. [PMC free article] [PubMed]
- Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease. Clinical Nephrology. 2010a;73:268–275.[PubMed]
- Kovesdy CP, Shinaberger CS, Kalantar-Zadeh K. Epidemiology of dietary nutrient intake in ESRD. Seminars in Dialysis. 2010b;23(4):353–358. [PMC free article] [PubMed]
- Ling PR, Smith RJ, Kie S, et al. Effects of protein malnutrition on IL-6-mediated signaling in the liver and the systemic acutephase response in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2004;287:R801–R808. [PubMed]
- Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney International. 2007;71:31–38. [PubMed]
- Martin CJ, Reams SM. The renal dietitian’s role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey. Journal of Renal Nutrition. 2003;13:133–136. [PubMed]
- Meade A. Protein supplementation with sports protein bars in renal patients. Journal of Renal Nutrition. 2007;17:214–217. [PubMed]
- Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney International. 2006;70:351–357.[PubMed]
- Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney International. 2006;69:1945–1953. [PubMed]
- Moe SM, Drueke T, Lameire N, et al. Chronic kidney disease-mineral-bone disorder: a new paradigm. Advances in Chronic Kidney Disease. 2007;14:3–12. [PubMed]
- Murphy-Gutekunst L. Hidden phosphorus: where do we go from here? Journal of Renal Nutrition. 2007;17:e31–e6.
- National Research Council, Food and Nutrition Board. Recommended Dietary Allowances. 10th. Washington, DC: National Academy Press; 1989. pp. 184–187.
- Noori N, Kalantar-Zadeh K, Kovesdy CP, et al. Dietary potassium intake and mortality in long-term hemodialysis patients. American Journal of Kidney Diseases. 2010a;56(2):338–347. [PMC free article][PubMed]
- Noori N, Kalantar-Zadeh K, Kovesdy CP, et al. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clinical Journal of the American Society of Nephrology. 2010b;5:683–692. [PMC free article] [PubMed]
- Noori N, Kopple JD, Kovesdy CP, et al. Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2010c [Epub ahead of print] [PMC free article] [PubMed]
- Noori N, Sims JJ, Kopple JD, et al. Organic and inorganic dietary phosphorus and its management in chronic kidney disease. Iranian Journal of Kidney Diseases. 2010d;4:89–100. [PubMed]
- Pecoits-Filho R. Dietary protein intake and kidney disease in Western diet. Contributions to Nephrology. 2007;155:102–112. [PubMed]
- Rambod M, Kovesdy CP, Bross R, et al. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. The American Journal of Clinical Nutrition. 2008;88:1485–1494. [PubMed]
- Rambod M, Bross R, Zitterkoph J, et al. Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. American Journal of Kidney Diseases. 2009;53:298–309. [PubMed]
- Shantouf RS, Budoff MJ, Ahmadi N, et al. Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. American Journal of Nephrology. 2010;31:419–425. [PMC free article] [PubMed]
- Shinaberger CS, Kilpatrick RD, Regidor DL, et al. Longitudinal associations between dietary protein intake and survival in hemodialysis patients. American Journal of Kidney Diseases. 2006;48:37–49.[PubMed]
- Shinaberger CS, Greenland S, Kopple JD, et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? The American Journal of Clinical Nutrition. 2008;88:1511–1518. [PubMed]
- Sullivan C, Sayre SS, Leon JB, et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA. 2009;301:629–635. [PubMed]
- Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Seminars in Dialysis. 2007;20:295–301. [PubMed]
Another study on egg whites: